HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- (biphenyl- 4- ylmethyl)- 1,2,3,4- tetrahydroisoquinoline- 6,7- diol

has antiglioma activity; structure in first source

Also Known As:

1-biPhMe-4HIQD

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Biphenyl Compounds: 7
        1-(biphenyl-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol: 1
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoquinolines: 34
      - 1-(biphenyl-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol: 1

Experts

1.	Geisert, Eldon E: 1 article (10/2008)
2.	Kang, Gyong-Suk: 1 article (10/2008)
3.	Kirichenko, Oleg V: 1 article (10/2008)
4.	Miller, Duane D: 1 article (10/2008)
5.	Mohler, Michael L: 1 article (10/2008)
6.	Orr, William E: 1 article (10/2008)
7.	Patil, Renukadevi: 1 article (10/2008)
8.	Wang, Xiang Di: 1 article (10/2008)

Related Diseases

1.	Glioma (Gliomas) 10/01/2008 - "The effects of 1-(biphenyl-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol (EDL-155) on the growth of glioma was tested in vitro and in vivo. "